Clinical Trial Update: Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating apixaban after anticoagulation-associated intracerebral hemorrhage in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cerebral Hemorrhage

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: UMC Utrecht | Conditions: Cerebral Hemorrhage, Atrial Fibrillation | Phase 2 | Status: COMPLETED